Following surgery, Teddy was started on empirical treatment with toceranib, a multi-receptor tyrosine kinase inhibitor and the only FDA-approved targeted cancer therapeutic for dogs, given the high risk for recurrent disease. Here, NTRK1 is linked to cancer.